Ogeda – Exit
New identity reflects Ogeda’s successful transition to GPCR drug discovery & development
Ogeda develops drugs to validated GPCR targets in the areas of women’s health, inflammation and neurodegenerative diseases.
| Sector: | Drug Discovery and Development |
| Country: | Belgium |
| Status: | Exit through trade sale |